相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Overview of multifunctional cysteinyl cathepsins in atherosclerosis-based cardiovascular disease: from insights into molecular functions to clinical implications
Xian Wu Cheng et al.
CELL AND BIOSCIENCE (2023)
Cathepsin K in Pathological Conditions and New Therapeutic and Diagnostic Perspectives
Olja Mijanovic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Cysteine cathepsins: A long and winding road towards clinics
Monika Biasizzo et al.
MOLECULAR ASPECTS OF MEDICINE (2022)
Assessment of serum and synovial fluid MMP-3 and MPO as biomarkers for psoriatic arthritis and their relation to disease activity indices
Mariela Geneva-Popova et al.
RHEUMATOLOGY INTERNATIONAL (2022)
Cathepsin g Degrades Both Glycosylated and Unglycosylated Regions of Lubricin, a Synovial Mucin
Shan Huang et al.
SCIENTIFIC REPORTS (2020)
Comorbidities associated with psoriatic arthritis: Review and update
Lourdes M. Perez-Chada et al.
CLINICAL IMMUNOLOGY (2020)
Heterotopic ossification of tendon and ligament
Qiang Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Psoriatic arthritis 1 The pathogenesis of psoriatic arthritis
Douglas J. Veale et al.
LANCET (2018)
Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score
Monika M. Schoels et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming
Khader Valli Rupanagudi et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Elastase and Cathepsin G from Primed Leukocytes Cleave Vascular Endothelial Cadherin in Hemodialysis Patientsd
Meital Cohen-Mazor et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)
Philip S. Helliwell et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Cathepsin K Is Involved in Development of Psoriasis-like Skin Lesions through TLR-Dependent Th17 Activation
Toshitake Hirai et al.
JOURNAL OF IMMUNOLOGY (2013)
Development of a preliminary composite disease activity index in psoriatic arthritis
Aizad Mumtaz et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Cathepsin K: A therapeutic target for bone diseases
Qingxiao Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Cathepsin K Regulates Adipocyte Differentiation: Possible Involvement of Type I Collagen Degradation
Junfeng Han et al.
ENDOCRINE JOURNAL (2009)
Biochemical properties and regulation of cathepsin K activity
Fabien Lecaille et al.
BIOCHIMIE (2008)
Neutrophil serine proteases fine-tune the inflammatory response
Christine T. N. Pham
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction
M Skoumal et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Cathepsin K expression in epithelioid and multinucleated giant cells
A Díaz et al.
JOURNAL OF PATHOLOGY (2002)
Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath
T Hansen et al.
MODERN PATHOLOGY (2001)
分享论文
